Lawmakers advanced a package to guarantee early voting, eliminate absentee ballot restrictions and automatically restore ballot access for some returning from incarceration.
Merck’s drug, molnupiravir, was found to reduce hospitalizations and deaths by 30 percent, while Pfizer's antiviral pill had a nearly 90 percent reduction.